Back to search
FDAFDA · Food and drugs·Recall number D-0042-2027

Metoclopramide Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-620-01; NDC Unit Dose: 60687-620-11

Published October 21, 2026 · Recall initiated: October 6, 2026

Summary

FDA records drug Class II recall D-0042-2027, published October 21, 2026 and initiated October 6, 2026. Recalling firm: American Health Packaging; Status: Ongoing; Reported quantity: 5,363 cartons; Lot: Lot 1028135, 1029555; Exp. Date 07/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablets/Capsules

What to do

Voluntary: Firm initiated · Letter

Get an email if METOCLOPRAMIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
METOCLOPRAMIDE
Manufacturer
American Health Packaging
Distributor
US Nationwide
Lot
Lot 1028135, 1029555; Exp. Date 07/31/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Metoclopramide Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-620-01; NDC Unit Dose: 60687-620-11 recalled?

Yes. FDA published recall D-0042-2027 on October 21, 2026. Reported hazard: Presence of Foreign Tablets/Capsules

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: METOCLOPRAMIDE.